COAGULARE BIOMEDICA LIMITED

Company Registration Number:
08084652 (England and Wales)

Unaudited micro entity accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

COAGULARE BIOMEDICA LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Footnotes to the Balance Sheet - 8

COAGULARE BIOMEDICA LIMITED

Company Information

for the Period Ended 31 March 2025




Director: John H. McVey
Registered office: Killiney House
Sheldons Lane
Walgrave
Northamptonshire
England
NN6 9PW
Company Registration Number: 08084652 (England and Wales)

COAGULARE BIOMEDICA LIMITED

Directors' Report Period Ended 31 March 2025

The directors present their report with the financial statements of the company for the period ended 31 March 2025

Principal Activities

Biomedical Consultancy

Political and charitable donations

None

Directors

The directors shown below have held office during the whole of the period from 01 April 2024 to 31 March 2025
John H. McVey

This report was approved by the board of directors on 30 September 2025
And Signed On Behalf Of The Board By:

Name: John H. McVey
Status: Director

COAGULARE BIOMEDICA LIMITED

Profit and Loss Account

for the Period Ended 31 March 2025


2025
£

2024
£
Turnover 300 2,260
Other charges ( 741 ) ( 1,156 )
Tax on Profit ( 0 ) ( 210 )
Profit or (Loss) for Period ( 441 ) 894

COAGULARE BIOMEDICA LIMITED

Balance sheet

As at 31 March 2025


2025
£

2024
£
Fixed Assets: 3,995 3,995
Current assets: 395 930
Creditors: amounts falling due within one year: ( 180 ) ( 300 )
Net current assets (liabilities): 215 630
Total assets less current liabilities: 4,210 4,625
Total net assets (liabilities): 4,210 4,625
Capital and reserves: 4,210 4,625

COAGULARE BIOMEDICA LIMITED

Balance sheet continued

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 30 September 2025
And Signed On Behalf Of The Board By:

Name: John H. McVey
Status: Director

The notes form part of these financial statements

COAGULARE BIOMEDICA LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2025

  • 1. Employee Information

    Average number of employees: 0

COAGULARE BIOMEDICA LIMITED

Footnotes to the Financial Statements

for the Period Ended 31 March 2025

  • 2. Off balance sheet disclosure

    No